Incyte's EPS (Weighted Average and Diluted) rose 29074.07% to $2.11 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9, marking a year-over-year increase of 411428.57%. This contributed to the annual value of $0.15 for FY2024, which is 9415.4% down from last year.
Per Incyte's latest filing, its EPS (Weighted Average and Diluted) stood at $2.11 for Q3 2025, which was up 29074.07% from $2.04 recorded in Q2 2025.
Incyte's EPS (Weighted Average and Diluted)'s 5-year high stood at $2.54 during Q4 2021, with a 5-year trough of -$2.04 in Q2 2024.
Over the past 5 years, Incyte's median EPS (Weighted Average and Diluted) value was $0.75 (recorded in 2024), while the average stood at $0.72.
In the last 5 years, Incyte's EPS (Weighted Average and Diluted) surged by 127142.86% in 2021 and then plummeted by 32666.67% in 2024.
Over the past 5 years, Incyte's EPS (Weighted Average and Diluted) (Quarter) stood at $2.54 in 2021, then plummeted by 95.28% to $0.12 in 2022, then surged by 641.67% to $0.89 in 2023, then increased by 7.39% to $0.96 in 2024, then skyrocketed by 120.77% to $2.11 in 2025.
Its last three reported values are $2.11 in Q3 2025, $2.04 for Q2 2025, and $0.8 during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value